Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: Modeling the influence of microenvironment

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 134-140

  Rama, Dorina ^a   Esendagli, Gunes ^a   Guc, Dicle ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cancer; Chemerin; Macrophage differentiation; Tumor microenvironment

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHEMOKINE LIKE RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL MATURATION; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MONOCYTE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

3T3-L1 CELLS; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOTACTIC FACTORS; COCULTURE TECHNIQUES; FEMALE; FIBROBLASTS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEOPLASMS; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052374155     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.016     Document Type: Article

References (34)

1. Yoshimura T., Oppenheim J.J. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties. Exp. Cell Res. 2011, 317:674-684.
2. Wittamer V., Franssen J.D., Vulcano M., Miriolet J.F., Poul E.L., Migeotte I., Brezillon S., Tyldeslev R., Blanpain C., Detheux M., Mantovani A., Sozzani S., Vassart G., Parmentier M., Communi D. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 2003, 198:977-985.
3. Zabel B.A., Silverio A.M., Butcher E.C. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J. Immunol. 2005, 174:244-251.
4. Vermi W., Riboldi E., Wittamer V., Gentili F., Luini W., Marrelli S., Vecchi A., Franssen J.D., Communi D., Massardi L., Sironi M., Mantovani A., Parmentier M., Facchetti F., Sozzani S. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 2005, 201:509-515.
5. Zabel B.A., Ohyama T., Zuniga L., Kim J.Y., Johnston B., Allen S.J., Guido D.G., Handel T.M., Butcher E.C. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp. Hematol. 2006, 34:1106-1114.
6. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., Communi S.D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A., Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
7. Kaur J., Adya R., Tan B.K., Chen J., Randeva H.S. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res Commun. 2010, 391:1762-1768.
8. Methner A., Hermey G., Schinke B., Hermans-Borgmeyer I. A novel G protein-coupled receptor with homology to neuropeptide and chemoattractant receptors expressed during bone development. Biochem. Biophys. Res. Commun. 1997, 233:336-342.
9. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., Serhan C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7671-7676.
10. Ohira T., Arita M. K. Omori K, A. Recchiuti A, T.E. Van Dyke, C.N. Serhan, Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 2010, 285:3451-3461.
11. Meder W., Wendland M., Busmann A., Kutzleb C., Spodsberg N., John H., Richter R., Schleuder D., Meyer M., Forssmann W.G. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 2003, 555:495-499.
12. Campbell E.L., Louis N.A., Tomassetti S.E., Canny G.O., Arita M., Serhan C.N., Colgan S.P. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 2007, 21:3162-3170.
13. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148:4687-4694.
14. Albanesi C., Scarponi C., Pallotta S., Daniele S.R., Bosisio D., Madonna S., Fortugno P., Gonzalvo-Feo S., Franssen J.D., Parmentier M., De Pita O., Girolomoni G., Sozzani S. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 2009, 206:249-258.
15. Luangsay S., Wittamer V., Bondue B., De Henau O., Rouger L., Brait M., Franssen J.D., de Nadai P., Huaux F., Parmentier M. Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model. J. Immunol. 2009, 183:6489-6499.
16. Weigert J., Obermeier F., Neumeier M., Wanninger J., Filarsky M., Bauer S., Slanidis C., Rogler G., Ott C., Schaffler A., Scholmerich J., Buechler C. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm. Bowel Dis. 2009, 16:630-637.
17. Lehrke M., Becker A., Greif M. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur. J. Endocrinol. 2009, 161:339-344.
18. Zabel B.A., Allen S.J., Kulig P., Allen J.A., Cichy J., Handel T.M., Butcher E.C. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J. Biol. Chem. 2005, 280:34661-34666.
19. Hart R., Greaves D.R. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J. Immunol. 2010, 185:3728-3739.
20. Cash J.L., Christian A.R., Greaves D.R. Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner. J. Immunol. 2010, 184:5315-5324.
21. Cash J.L., Hart R., Russ A., Dixon J.P., Colledge W.H., Doran J., Hendrick A.G., Carlton M.B., Greaves D.R. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 2008, 205:767-775.
22. Jacob S.S., Shastry P., Sudhakaran P.R. Monocyte-macrophage differentiation in vitro: modulation by extracellular matrix protein substratum. Mol. Cell. Biochem. 2002, 233:9-17.
23. Mantovani A., Sica A., Allavena P., Garlanda C., Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 2009, 70:325-330.
24. Legrand O., Perrot J., Simonin G., Baudard M., Marie J. JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 2001, 97:502-508.
25. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:2003-2007.
26. Overbergh L., Giulietti A., Valckx D., Decallonne R., Bouillon R., Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 2003, 14:33-43.
27. Abbas A.K., Lichtman A.H., Pober J.S. Innate immunity In: Cellular and molecular immunology 2003, W.B. Saunders Co., Philadelphia, p. 275.
28. Steinhauser M.L., Kunkel S.L., Hogaboam C.M., Evanoff H., Strieter R.M., Lukacs N.W. Macrophage/fibroblast coculture induces macrophage inflammatory protein-1alpha production mediated by intercellular adhesion molecule-1 and oxygen radicals. J. Leukoc. Biol. 1998, 64:636-641.
29. Ishikawa K., Yamasawa H., Sugiyama Y. Human lung fibroblasts inhibit macrophage inflammatory protein-1alpha production by lipopolysaccharide-stimulated macrophages. Biochem. Biophys. Res. Commun. 2003, 312:650-655.
30. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
31. Leenen P.J., de Bruijn M.F., Voerman J.S., Campbell P.A., van Ewijk W. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods. 1994, 174(1-2):5-19.
32. Fernandez-Ranvier G.G., Weng J., Yeh R.F., Khanafshar E., Suh I., Barker C., Duh Q.Y., Clark O.H., Kebebew E. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch. Surg. 2008, 143:841-846.
33. Zheng Y., Luo S., Wang G., Peng Z., Zeng W., Tan S., Xi Y., Fan J. Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma. Eur. J. Dermatol. 2008, 18:638-641.
34. Prasse A., Pechkovsky D.V., Toews G.B., Jungraithmayr W., Kollert F., Goldmann T., Vollmer E., Muller-Quernheim J., Zissel G. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 2006, 173:781-792.